Posted in | News | Lighting

Ceravision Joins Toshiba Electronics for Development of Advanced Magnetrons

Ceravision Ltd, the inventor and world leader in High Efficiency Plasma (HEP) technology has formed a strategic alliance with Toshiba Electronics to accelerate development of advanced magnetrons for lighting applications.

Tim Reynolds, Ceravision's CEO, states: "We are delighted to have Toshiba Electronics as our partner. This programme will allow us to further develop the efficiency of our technology with a world-class provider. Our supply agreement with Toshiba will also further enhance the quality of our components, as well as giving confidence to our customers that their volume requirements can be met. We have tried and tested many commercial magnetrons over the last year and Toshiba has consistently demonstrated industry-leading performance.

"Whilst our High Efficiency Plasma technology's performance already greatly exceeds that of incumbent technologies, achieving even greater efficiencies remains our primary goal. This partnership will allow us to extend our system's advantages, whilst further increasing the amount of energy our products save."

Ted Schurch, General Manager Sales, Toshiba Electronics Europe, comments: "Ceravision is a highly innovative company whose technology advances are leading the way in the development of new forms of high efficiency lighting. Toshiba is pleased that its super high efficiency magnetrons have been judged by Ceravision to be the best partners for its groundbreaking system."

Ceravision will shortly be releasing its first product family incorporating all of the benefits of High Efficiency Plasma. These include power savings of up to 67%, a reduction in the number of fittings of up to 50%, extended lifetimes and increased intelligent lighting controls. Named the Alvara (TM) range, the first product will be the Alvara (TM) 400, which has been designed to replace existing 400W products. Other products for sectors such as street lighting are due to follow shortly afterwards.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.